110 related articles for article (PubMed ID: 8874502)
1. The V3 domain of SIVmac251 gp120 contains a linear neutralizing epitope.
Palker TJ; Muir AJ; Spragion DE; Staats HF; Langlois A; Montefiori DC
Virology; 1996 Oct; 224(2):415-26. PubMed ID: 8874502
[TBL] [Abstract][Full Text] [Related]
2. Development of HIV/AIDS vaccine using chimeric gag-env virus-like particles.
Kang CY; Luo L; Wainberg MA; Li Y
Biol Chem; 1999 Mar; 380(3):353-64. PubMed ID: 10223338
[TBL] [Abstract][Full Text] [Related]
3. The majority of neutralizing Abs in HIV-1-infected patients recognize linear V3 loop sequences. Studies using HIV-1MN multiple antigenic peptides.
Vogel T; Kurth R; Norley S
J Immunol; 1994 Aug; 153(4):1895-904. PubMed ID: 7519220
[TBL] [Abstract][Full Text] [Related]
4. Antigenic variation of SIV: mutations in V4 alter the neutralization profile.
Kinsey NE; Anderson MG; Unangst TJ; Joag SV; Narayan O; Zink MC; Clements JE
Virology; 1996 Jul; 221(1):14-21. PubMed ID: 8661410
[TBL] [Abstract][Full Text] [Related]
5. Ability of the V3 loop of simian immunodeficiency virus to serve as a target for antibody-mediated neutralization: correlation of neutralization sensitivity, growth in macrophages, and decreased dependence on CD4.
Means RE; Matthews T; Hoxie JA; Malim MH; Kodama T; Desrosiers RC
J Virol; 2001 Apr; 75(8):3903-15. PubMed ID: 11264379
[TBL] [Abstract][Full Text] [Related]
6. Induction of HIVMN neutralizing antibodies in primates using a prime-boost regimen of hybrid synthetic gp120 envelope peptides.
Haynes BF; Torres JV; Langlois AJ; Bolognesi DP; Gardner MB; Palker TJ; Scearce RM; Jones DM; Moody MA; McDanal C
J Immunol; 1993 Aug; 151(3):1646-53. PubMed ID: 8335949
[TBL] [Abstract][Full Text] [Related]
7. Characterization of neutralization epitopes of simian immunodeficiency virus (SIV) recognized by rhesus monoclonal antibodies derived from monkeys infected with an attenuated SIV strain.
Cole KS; Alvarez M; Elliott DH; Lam H; Martin E; Chau T; Micken K; Rowles JL; Clements JE; Murphey-Corb M; Montelaro RC; Robinson JE
Virology; 2001 Nov; 290(1):59-73. PubMed ID: 11883006
[TBL] [Abstract][Full Text] [Related]
8. Studies of the conformation-dependent neutralizing epitopes of simian immunodeficiency virus envelope protein.
Javaherian K; Langlois AJ; Montefiori DC; Kent KA; Ryan KA; Wyman PD; Stott J; Bolognesi DP; Murphey-Corb M; Larosa GJ
J Virol; 1994 Apr; 68(4):2624-31. PubMed ID: 7511176
[TBL] [Abstract][Full Text] [Related]
9. Cross-neutralization of human immunodeficiency virus type 1 and 2 and simian immunodeficiency virus isolates.
Robert-Guroff M; Aldrich K; Muldoon R; Stern TL; Bansal GP; Matthews TJ; Markham PD; Gallo RC; Franchini G
J Virol; 1992 Jun; 66(6):3602-8. PubMed ID: 1374810
[TBL] [Abstract][Full Text] [Related]
10. Focusing the immune response on the V3 loop, a neutralizing epitope of the HIV-1 gp120 envelope.
Zolla-Pazner S; Cohen SS; Krachmarov C; Wang S; Pinter A; Lu S
Virology; 2008 Mar; 372(2):233-46. PubMed ID: 18061228
[TBL] [Abstract][Full Text] [Related]
11. The effect of low-profile serine substitutions in the V3 loop of HIV-1 gp120 IIIB/LAI on the immunogenicity of the envelope protein.
Peet NM; McKeating JA; de Souza JB; Roitt IM; Delves PJ; Lund T
Virology; 1998 Nov; 251(1):59-70. PubMed ID: 9813203
[TBL] [Abstract][Full Text] [Related]
12. Immunogenicity comparison of a multi-antigenic peptide bearing V3 sequences of the human immunodeficiency virus type 1 with TAB9 protein in mice.
Cruz LJ; Quintana D; Iglesias E; Garcia Y; Huerta V; Garay HE; Duarte C; Reyes O
J Pept Sci; 2000 May; 6(5):217-24. PubMed ID: 10823490
[TBL] [Abstract][Full Text] [Related]
13. Structural and immunological reactivity of the principal neutralizing determinant V3 of glycoprotein gp120 of HIV-1.
Borbe HC; Stuber G; Wagner R; Wolf H; Modrow S
J Pept Sci; 1995; 1(2):109-23. PubMed ID: 9222988
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of immune responses induced by HIV-1 gp120 in rhesus macaques: effect of vaccination on challenge with pathogenic strains of homologous and heterologous simian human immunodeficiency viruses.
Kumar A; Lifson JD; Silverstein PS; Jia F; Sheffer D; Li Z; Narayan O
Virology; 2000 Aug; 274(1):149-64. PubMed ID: 10936096
[TBL] [Abstract][Full Text] [Related]
15. [Evaluation of diagnostic efficiency of the recombinant protein modeling immunodominant epitope V3 of envelope gp120 for immunoenzyme detection for HIV-1 infection antibodies].
Riabinina SA; Baranova EN; Sharipova IN; Susekina MI; Puzyrev VF; Obriadina AP; Burkov AN; Ulanova TI
Mol Gen Mikrobiol Virusol; 2007; (3):33-6. PubMed ID: 17886471
[TBL] [Abstract][Full Text] [Related]
16. Structure-antigenicity of the V3 region of SIVmac envelope glycoprotein.
Gaston F; Babas T; Lakhdar-Ghazal F; Bahraoui E
J Pept Sci; 2010 Jan; 16(1):48-57. PubMed ID: 19908202
[TBL] [Abstract][Full Text] [Related]
17. Heterologous neutralizing antibody induction in a simian-human immunodeficiency virus primate model: lack of original antigenic sin.
Rasmussen RA; Montefiori DC; Robinson HL; McClure HM; Ruprecht RM
J Infect Dis; 2001 Dec; 184(12):1603-7. PubMed ID: 11740737
[TBL] [Abstract][Full Text] [Related]
18. Characterization of B-cell epitopes in the envelope glycoproteins of simian immunodeficiency virus.
Benichou S; Venet A; Beyer C; Tiollais P; Madaule P
Virology; 1993 Jun; 194(2):870-4. PubMed ID: 7684879
[TBL] [Abstract][Full Text] [Related]
19. Neutralizing monoclonal antibody against a external envelope glycoprotein (gp110) of SIVmac251.
Matsumi S; Matsushita S; Yoshimura K; Javaherian K; Takatsuki K
AIDS Res Hum Retroviruses; 1995 Apr; 11(4):501-8. PubMed ID: 7632464
[TBL] [Abstract][Full Text] [Related]
20. Design of immunogens that present the crown of the HIV-1 V3 loop in a conformation competent to generate 447-52D-like antibodies.
Chakraborty K; Durani V; Miranda ER; Citron M; Liang X; Schleif W; Joyce JG; Varadarajan R
Biochem J; 2006 Nov; 399(3):483-91. PubMed ID: 16827663
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]